Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009603 220003926 1.85 83.6 Not known (9) 2016-04-20 2016-04-21 Methotrexate intrathecal 2 N 220022925 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009604 220003927 1.58 53.6 Curative (C) 2013-10-02 2013-10-03 BOSUTINIB 2 N 220023120 CYTARABINE + MITOXANTRONE
220009605 220003928 1.76 70 Curative (C) 2014-09-21 2015-07-06 PONATINIB N N 220023196 PONATINIB
220009606 220003928 1.78 92.3 Curative (C) 2016-11-20 2017-01-06 CISPLATIN + FLUOROURACIL N N 220023196 TRIPLE INTRATHECAL
220009607 220003928 1.78 95 Curative (C) 2017-03-16 2017-03-16 Vemurafenib 02 N 220023196 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220009608 220021345 1.77 75.5 Curative (C) 2015-05-06 2015-05-06 CAPECITABINE + CISPLATIN + EPIRUBICIN N N 220023457 FLUDARABINE + MELPHALAN
220009609 220021345 1.58 67 Curative (C) 2016-01-02 2016-01-04 Vemurafenib 02 N 220023457 IDARUBICIN + MITOXANTRONE + TRETINOIN
220009610 220021345 1.6 48 Palliative (P) null 2019-07-31 VINCRISTINE N N 220023457 DOXORUBICIN + IFOSFAMIDE
220009611 220021345 1.73 null Palliative (P) 2013-04-15 2013-04-30 Alemtuzumab(INTRAVENOUS) N null 220023457 CAPECITABINE + EPIRUBICIN + OXALIPLATIN
220009612 220021345 null 105.3 Curative (C) 2015-11-30 2015-12-08 LENALIDOMIDE N N 220023457 CISPLATIN
220009613 220022172 1.56 83 Curative (C) 2015-10-13 2015-10-13 FLUDARABINE null null 220023638 CODOX M
220009614 220003929 1.62 null Not known (9) 2018-07-09 2018-07-27 Ipilimumab N N 220023658 UKALL2014
220009615 220003930 null null Curative (C) 2015-12-07 2015-12-30 Fludarabine + Melphalan RIC Allo N null 220023660 ARSENIC TRIOXIDE + ATRA
220009616 220003930 1.59 null Palliative (P) 2018-02-21 2018-03-12 Arsenic Trioxide (consolidation) null null 220023660 CHOP R
220009617 220003930 null 74.6 null 2018-03-15 2018-03-18 ATG + Busulfan + Fludarabine 02 N 220023660 CYTARABINE INTRATHECAL
220009618 220003930 1.55 88.9 Disease modification (D) 2016-09-14 2016-09-14 IDARUBICIN + MITOXANTRONE + Tretinoin 02 N 220023660 IBRUTINIB
220009619 220003930 null 63.6 Curative (C) 2014-07-17 2014-07-17 LANREOTIDE N N 220023660 CHOP R
220009620 220003930 1.71 null Curative (C) 2017-07-23 2017-07-23 CHOP N N 220023660 LI-1 TRIAL
220009621 220003931 1.57 74.4 null 2015-11-08 2016-01-06 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE 02 N 220023979 CYTARABINE INTRATHECAL
220009622 220003932 2 95 Curative (C) 2015-09-11 2015-09-22 Mitoxantrone 2 null 220023980 ARSENIC TRIOXIDE + ATRA
220009623 220012100 null null Disease modification (D) 2013-06-24 2013-06-24 Fludarabine + Melphalan RIC Allo null null 220023986 QUASAR 2 TRIAL
220009624 220012100 0 53.7 Not known (9) 2016-06-11 2016-06-11 Docetaxel + Trastuzumab (Load) 01 N 220023986 BLEOMYCIN + CISPLATIN + VINCRISTINE
220009625 220003933 0 67.2 Palliative (P) 2016-05-27 2016-06-07 Bortezomib +/- Dexamethasone 2 N 220024069 MITOXANTRONE
220009626 220003933 1.59 null null 2015-03-15 2015-03-15 AML LI-1 Trial N Y 220024069 METHOTREXATE HIGH DOSE
220009627 220003933 1.5 0 Curative (C) 2014-08-02 2014-08-02 LENALIDOMIDE N Y 220024069 CISPLATIN + FLUOROURACIL
220009628 220003933 1.67 null Palliative (P) 2015-12-01 2015-12-24 Mitox + Tretinoin Spanish Course 3 02 null 220024069 IPILIMUMAB
220009629 220003934 null null Curative (C) 2017-01-01 2017-01-03 LENALIDOMIDE N N 220024209 CYTARABINE INTRATHECAL
220009630 220003935 null 119.4 null null 2017-11-17 Sunitinib Y N 220024226 FLUDARABINE
220009631 220003935 0 null null 2017-05-03 2017-05-06 Epirubicin N N 220024226 ECF
220009632 220003935 1.68 67.4 Curative (C) 2018-09-06 2018-09-06 Cisplatin + Pemetrexed 02 N 220024226 CVD
220009633 220003935 1.65 4.3 Curative (C) 2018-02-10 2018-02-12 Capecitabine 2 N 220024226 MITOXANTRONE
220009634 220003935 1.55 63.8 Palliative (P) 2015-03-16 2015-03-16 AML LI-1 Trial N N 220024226 DACARBAZINE
220009635 220003936 1.66 59.7 Curative (C) 2018-08-22 2018-08-22 Triple / Double Intrathecal Therapy N N 220024698 CISPLATIN
220009636 220003936 null 69.8 Curative (C) 2016-02-07 2016-02-07 MELPHALAN N N 220024698 ARSENIC TRIOXIDE + TRETINOIN
220009637 220003936 1.63 null Palliative (P) 2019-01-19 2019-02-15 AML LI-1 Trial 02 N 220024698 CARBO + FLUOROURACIL
220009638 220003937 1.82 68.45 Palliative (P) 2016-08-08 2016-09-03 Cisplatin N Y 220025003 DABRAFENIB + TRAMETINIB
220009639 220003937 1.5 null Palliative (P) null 2016-02-16 Mitoxantrone null N 220025003 CISPLATIN + FLUOROURACIL
220009640 220003937 1.61 112 Palliative (P) 2017-05-07 2017-05-08 CYTARABINE + MITOXANTRONE 02 null 220025003 DOXORUBICIN + IFOSFAMIDE
220009641 220003937 1.65 87 Curative (C) 2016-07-26 2016-09-09 Alemtuzumab cond (RI ALLO CAMP100) N N 220025003 ATG + BUSULFAN + FLUDARABINE
220009642 220003937 null null null null 2015-09-19 Cape+Cisplatin+Trastuzumab Load 99 null 220025003 UKALL XII
220009643 220003937 1.67 83.7 Palliative (P) 2016-08-29 2016-09-04 Irinotecan + Modified De Gramont 2 N 220025003 DACARBAZINE
220009644 220003938 1.82 59.1 Curative (C) null 2017-05-25 ECarboX N N 220025372 MITOXANTRONE
220009645 220012105 1.67 null Disease modification (D) 2016-11-30 2016-12-22 Bortezomib + MELPHALAN N N 220025376 RUXOLITINIB
220009646 220003939 1.6 null null 2015-01-20 2015-01-20 FLUOROURACIL N N 220025427 UKALL2014
220009647 220003939 0 71 Curative (C) 2015-10-15 2015-10-15 LENALIDOMIDE 02 N 220025427 CYTARABINE + MITOXANTRONE
220009648 220003939 1.73 0 Not known (9) 2014-07-01 2014-07-06 Carboplatin + Pemetrexed 2 N 220025427 THALIDOMIDE
220009649 220003939 1.67 114.5 null 2016-03-09 2016-04-23 ETOPOSIDE + IFOSFAMIDE N N 220025427 ARSENIC TRIOXIDE
220009650 220003939 null 87.3 Palliative (P) null 2017-01-26 AXITINIB N N 220025427 CISPLATIN + PEMETREXED
220009651 220003940 null null Curative (C) null 2019-07-31 OCTREOTIDE null null 220026026 ARSENIC TRIOXIDE
220009652 220003941 1.75 0 Curative (C) 2013-06-01 2013-07-17 Cyclophosphamide TBI Allograft N N 220026030 MITOXANTRONE